Serum neuron-specific enolase is elevated as a novel indicator of diabetic retinopathy including macular oedema

Diabetic Medicine

Volumn 32, Issue 1, 2015, Pages 102-107

  Li, J ^a   Yan, M ^a   Zhang, Y ^a   Xie, M ^a   Yan, L ^a   Chen, J ^a  

^a THE FIRST AFFILIATED HOSPITAL OF NANJING MEDICAL UNIVERSITY   (China)

Author keywords

[No Author keywords available]

Indexed keywords

AGENTS AFFECTING LIPID METABOLISM; ALBUMIN; ANGIOTENSIN 2 RECEPTOR ANTAGONIST; ANTIDIABETIC AGENT; ANTIHYPERTENSIVE AGENT; BIGUANIDE; CREATININE; DIPEPTIDYL CARBOXYPEPTIDASE INHIBITOR; HEMOGLOBIN A1C; HIGH DENSITY LIPOPROTEIN CHOLESTEROL; INSULIN; NEURON SPECIFIC ENOLASE; SULFONYLUREA DERIVATIVE; THIAZOLIDINE DERIVATIVE; TRIACYLGLYCEROL; BIOLOGICAL MARKER; ENOLASE;

ADULT; AGE DISTRIBUTION; AGED; ALBUMIN BLOOD LEVEL; AREA UNDER THE CURVE; ARTICLE; BLOOD SAMPLING; CHOLESTEROL BLOOD LEVEL; CONTROLLED STUDY; CORRELATION ANALYSIS; CREATININE BLOOD LEVEL; CROSS-SECTIONAL STUDY; DIABETIC MACULAR EDEMA; DIABETIC RETINOPATHY; DISEASE DURATION; EYE FUNDUS; EYE PHOTOGRAPHY; FEMALE; HEMOGLOBIN BLOOD LEVEL; HUMAN; INSULIN DEPENDENT DIABETES MELLITUS; KIDNEY FUNCTION; MAJOR CLINICAL STUDY; MALE; NON INSULIN DEPENDENT DIABETES MELLITUS; RECEIVER OPERATING CHARACTERISTIC; SENSITIVITY AND SPECIFICITY; SEX DIFFERENCE; TRIACYLGLYCEROL BLOOD LEVEL; BLOOD; COMPLICATION; DIET RESTRICTION; FLUORESCENCE ANGIOGRAPHY; MACULAR EDEMA; MIDDLE AGED; OXIDATIVE STRESS; PROGNOSIS; QUESTIONNAIRE;

ADULT; BIOLOGICAL MARKERS; CROSS-SECTIONAL STUDIES; DIABETES MELLITUS, TYPE 1; DIABETES MELLITUS, TYPE 2; DIABETIC RETINOPATHY; FASTING; FEMALE; FLUORESCEIN ANGIOGRAPHY; HUMANS; MACULAR EDEMA; MALE; MIDDLE AGED; OXIDATIVE STRESS; PHOSPHOPYRUVATE HYDRATASE; PROGNOSIS; QUESTIONNAIRES;

EID: 84916607504     PISSN: 07423071     EISSN: 14645491     Source Type: Journal    
DOI: 10.1111/dme.12597     Document Type: Article

References (23)

1. Yang W, Lu J, Weng J, Jia W, Ji L, Xiao J. China National Diabetes and Metabolic Disorders Study Group. Prevalence of diabetes among men and women in China. N Engl J Med 2010; 362: 1090-1101.
2. Bunce C, Wormald R. Causes of blind certifications in England and Wales: April 1999-March 2000. Eye (Lond) 2008; 22: 905-911.
3. Browning DJ, Fraser CM, Clark S. The relationship of macular thickness to clinically graded diabetic retinopathy severity in eyes without clinically detected diabetic macular edema. Ophthalmology 2008; 115: 533-539.
4. van Dijk HW, Verbraak FD, Kok PH, Stehouwer M, Garvin MK, Sonka M et al. Early neurodegeneration in the retina of type 2 diabetic patients. Invest Ophthalmol Vis Sci 2012; 53: 2715-2719.
5. Jackson GR, Barber AJ. Visual dysfunction associated with diabetic retinopathy. Curr Diabetes Rep 2010; 109: 380-384.
6. Barber AJ. A new view of diabetic retinopathy: a neurodegenerative disease of the eye. Prog Neuropsychopharmacol Biol Psychiat 2003; 27: 283-290.
7. Kaiser E, Kuzmits R, Pregant P, Burghuber O, Worofka W. Clinical biochemistry of neuron specific enolase. Clin Chim Acta 1989; 183: 13-31.
8. Mielke R, Schroder R, Fink GR, Kessler J, Herholz K, Heiss WD. Regional cerebral glucose metabolism and postmortem pathology in Alzheimer's disease. Acta Neuropathol 1996; 91: 174-179.
9. Marangos PJ, Schmechel DE. Neuron specific enolase, a clinically useful marker for neurons and neuroendocrine cells. Annu Rev Neurosci 1987; 10: 269-295.
10. Yee KM, Ross-Cisneros FN, Lee JG, Da Rosa AB, Salomao SR, Berezovsky A et al. Neuron-specific enolase is elevated in asymptomatic carriers of Leber's hereditary optic neuropathy. Invest Ophthalmol Vis Sci 2012; 53: 6389-6392.
11. Sandhu HS, Butt AN, Powrie J, Swaminathan R. Measurement of circulating neuron-specific enolase mRNA in diabetes mellitus. Ann NY Acad Sci 2008; 1137: 258-263.
12. Li J, Zhang H, Xie M, Yan L, Chen J, Wang H. NSE, a potential biomarker, is closely connected to diabetic peripheral neuropathy. Diabetes Care 2013; 36: 3405-3410.
13. Wilkinson CP, Ferris FL III, Klein RE et al. Proposed international clinical diabetic retinopathy and diabetic macular edema disease severity scales. Ophthalmology 2003; 110: 1677-1682.
14. Early Treatment Diabetic Retinopathy Study Research Group. Photocoagulation for diabetic maculopathy. Arch Ophthalmol 1985; 103: 1796-1806.
15. Summary of Revisions for the 2006 Clinical Practice Recommendations. Diabetes Care 2006; 29 Suppl 1: S3.
16. Price TO, Eranki V, Banks WA, Ercal N, Shah GN. Topiramate treatment protects blood-brain barrier pericytes from hyperglycemia-induced oxidative damage in diabetic mice. Endocrinology 2012; 153: 362-372.
17. Beltramo E, Porta M. Pericyte loss in diabetic retinopathy: mechanisms and consequences. Curr Med Chem 2013; 20: 3218-3225.
18. Clegg N, Ferguson C, True LD, Arnold H, Moorman A, Quinn JE et al. Molecular characterization of prostatic small-cell neuroendocrine carcinoma. Prostate 2003; 55: 55-64.
19. Kasprzak A, Zabel M, Biczysko W. Selected markers (chromogranin A, neuron-specific enolase, synaptophysin, protein gene product 9.5) in diagnosis and prognosis of neuroendocrine pulmonary tumours. Pol J Pathol 2007; 58: 23-33.
20. Nemeth J, Galian A, Mikol J, Cochand-Priollet B, Wassef M, Lavergne A et al. Neuron-specific enolase and malignant lymphomas (23 cases). Pathol Anat Histopathol 1987; 412: 89-93.
21. Selakovic V, Raicevic R, Radenovic L. The increase of neuron-specific enolase in cerebrospinal fluid and plasma as a marker of neuronal damage in patients with acute brain infarction. J Clin Neurosci 2005; 12: 542-547.
22. Wunderlich MT, Ebert AD, Kratz T, Goertler M, Jost S, Herrmann M. Early neurobehavioral outcome after stroke is related to release of neurobiochemical markers of brain damage. Stroke 1999; 30: 1190-1195.
23. Li J, Zhang H, Shi M, Yan L, Xie M. Homocysteine is linked to macular edema in type 2 diabetes. Curr Eye Res 2014; 39: 730-735.